Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-13 5:15 pm Sale | 2024-12-13 | 13G | AC Immune S.A. ACIU | AFFIRIS AG in Liqu | 6,428,100 6.500% | -150,000 (-2.28%) | Filing History |
| 2024-11-14 4:36 pm Purchase | 2024-09-30 | 13G | AC Immune S.A. ACIU | BIOTECHNOLOGY VALUE FUND L P | 19,522,436 19.700% | 4,951,200 (+33.98%) | Filing History |
| 2024-02-09 4:30 pm Sale | 2023-12-15 | 13G | AC Immune S.A. ACIU | AFFIRIS AG in Liqu | 6,578,100 6.660% | -146,740 (-2.18%) | Filing History |
| 2023-12-19 4:53 pm Purchase | 2023-12-15 | 13G | AC Immune S.A. ACIU | BIOTECHNOLOGY VALUE FUND L P | 14,571,236 14.800% | 7,142,857 (+96.16%) | Filing History |
| 2023-02-14 5:15 pm Sale | 2022-10-06 | 13G | AC Immune S.A. ACIU | AFFIRIS AG in Liqu | 6,724,840 8.060% | -1,895,317 (-21.99%) | Filing History |
| 2023-02-13 5:53 pm Purchase | 2022-12-31 | 13G | AC Immune S.A. ACIU | BIOTECHNOLOGY VALUE FUND L P | 7,428,379 8.900% | 366,000 (+5.18%) | Filing History |
| 2023-02-10 4:01 pm Sale | 2022-12-31 | 13G | AC Immune S.A. ACIU | dievini Hopp BioTech holding GmbH & Co. KG | 16,316,742 19.500% | -1,724,258 (-9.56%) | Filing History |
| 2023-01-27 4:41 pm Unchanged | 2022-12-31 | 13G | AC Immune S.A. ACIU | ELI LILLY & Co LLY | 3,615,328 4.300% | 0 (Unchanged) | Filing History |
| 2022-02-14 1:41 pm Sale | 2021-12-31 | 13G | AC Immune S.A. ACIU | BIOTECHNOLOGY VALUE FUND L P | 7,062,379 9.700% | -854,279 (-10.79%) | Filing History |
| 2022-02-14 1:37 pm Sale | 2021-12-31 | 13G | AC Immune S.A. ACIU | EcoR1 Capital, LLC | 749,585 0.900% | -3,952,575 (-84.06%) | Filing History |
| 2021-08-05 5:15 pm Purchase | 2021-07-26 | 13G | AC Immune S.A. ACIU | AFFIRIS AG in Liqu | 8,620,157 10.100% | 8,620,157 (New Position) | Filing History |
| 2021-02-12 4:50 pm Purchase | 2020-12-31 | 13G | AC Immune S.A. ACIU | ELI LILLY & Co LLY | 3,615,328 5.000% | 3,615,328 (New Position) | Filing History |
| 2021-02-12 10:59 am Sale | 2020-12-31 | 13G | AC Immune S.A. ACIU | dievini Hopp BioTech holding GmbH & Co. KG | 18,041,000 25.100% | -174,750 (-0.96%) | Filing History |
| 2021-01-22 4:27 pm Purchase | 2021-01-12 | 13G | AC Immune S.A. ACIU | EcoR1 Capital, LLC | 4,702,160 6.600% | 4,702,160 (New Position) | Filing History |
| 2021-01-14 4:48 pm Sale | 2021-01-12 | 13G | AC Immune S.A. ACIU | BIOTECHNOLOGY VALUE FUND L P | 7,916,658 11.000% | -3,425,847 (-30.20%) | Filing History |